Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-200P (RNA, U7 small nuclear 200 pseudogene) is a human pseudogene corresponding to U7 small nuclear RNA. It is not believed to encode a functional transcript or protein. Functional U7 snRNA is a component of the U7 small nuclear ribonucleoprotein complex, crucial for 3' end processing of replication-dependent histone pre-mRNAs[1][3]. As a pseudogene, RNU7-200P lacks evidence of biological activity and is not considered a therapeutic or drug discovery target. It should be distinguished from the functional U7 snRNA gene, which participates in histone mRNA processing. There is no established disease association, functional role, biomarker value, or pharmacological interaction for RNU7-200P. This entry may be incorrect if intended for a therapeutically actionable target, as it is a non-functional genomic element rather than an active molecular entity[1][2][4].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 200 pseudogene (RNU7-200P).